||| Menü 
Startseite
Firmenveranstaltungen, Neuemissionen

10/11
09/11
08/11
07/09
08/09
09/09
10/09
11/09
12/09
01/10
02/10
03/10
Geschäftsberichte, Werbung, Earnings, Marketing, Verordnungen

10/11
09/11
03/09
04/09
05/09
06/09
08/09
09/09
10/09
11/09
12/09
01/10
02/10
Fusionen, Übernahmen

11/11
12/08
01/09
02/09
03/09
04/09
05/09
06/09
07/09
08/09
09/09
10/09
11/09
Personal, Belegschaft, Meldungen zu Produkten

06/08
07/08
08/08
09/08
10/08
11/08
12/08
01/09
02/09
03/09
04/09
05/09
06/09
07/09
08/09

Kontakt
Impressum
Bankleitzahlen - online.de


Dr. Christian Müller to be appointed new CFO of Carl Zeiss Meditec

Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------




JENA - 11 December 2009.
Dr. Christian Müller (42) is to be appointed as a new member of the
Management Board and Chief Financial Officer of Carl Zeiss Meditec AG
with effect from 15 December 2009. This was resolved by the
Supervisory Board at its meeting yesterday. Dr. Müller shall succeed
Bernd Hirsch, who left the company at his own request on 30 November
2009.

Müller, who has a PhD in Business Administration, began his career
with the Carl Zeiss Group in 2002 in the area of auditing and risk
management. Before that, Müller held a number of managerial positions
within the Controlling departments of two large international
corporations. From 2006 until the present day, Müller has been
responsible for the Surgical Ophthalmology strategic business unit
(SBU). During this time Müller has actively and successfully driven
forward the expansion of this SBU and realised the integration of
Acri.Tec. In his new role as a member of the Management Board and CFO
of Carl Zeiss Meditec, Dr. Müller shall be responsible for the areas
of finance, investor relations and IT. He shall continue, within the
Management Board, to oversee the activities of the Surgical
Ophthalmology SBU, the operative responsibility of which, however,
will be delegated as of 1 February 2010


Dr. Markus Guthoff, Chairman of the Supervisory Board of Carl Zeiss
Meditec, commented: "We are delighted to be able to appoint Dr.
Christian Müller, a proven specialist and expert in our business,
from within our own ranks as our new CFO. We are confident that Dr.
Müller will be a very strong addition to our successful Management
Board team."

The Company shall publish its annual financial statements next Monday
on 14 December 2009.


Press contacts:
Eva Sesselmann
Corporate Communications
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
Phone: +49 3641 220-331
Phone: +49 3641 220-112
E-mail: press@meditec.zeiss.com

Patrick Kofler
Investor relations
Carl Zeiss Meditec AG
Göschwitzer Straße 51-52
07745 Jena
Phone: +49 3641 220-106
Phone: +49 3641 220-117
E-mail: investors@meditec.zeiss.com


Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704) is one of the world's
leading medical technology suppliers. The company supplies innovative
technologies and application-oriented solutions designed to help
doctors improve the quality of life of their patients. It provides
complete packages of solutions for the diagnosis and treatment of eye
diseases - including implants and consumable materials. The company
creates innovative visualisation solutions in the field of
microsurgery. Carl Zeiss Meditec's medical technology portfolio is
rounded off by promising future technologies such as intraoperative
radiation therapy.

In the 2007/2008 (30 September) financial year the 2,100 employees
generated revenue of approximately ¤ 600 million. The head office of
Carl Zeiss Meditec is in Jena, Germany. The company has subsidiaries
in Germany and abroad; more than 50 percent of its employees are
based in the USA, Japan, Spain and France.

35 percent of Carl Zeiss Meditec shares are in free float. The
remaining 65 percent are held by Carl Zeiss AG, one of the world's
leading groups engaged in the optical and opto-electronics industry.
The five independently managed business units of Carl Zeiss AG
operate in the future-oriented markets of "Medical and Research
Solutions", "Industrial Solutions" and "Lifestyle Products". The head
office of Carl Zeiss AG is in Oberkochen, Germany. In financial year
2007/08 (balance sheet date 30 September) the group posted sales of
around ¤ 2.7 billion. Carl Zeiss has a total workforce of about
13,000 in over 30 countries, over 8,000 of them in Germany.

Further information: www.meditec.zeiss.de



--- End of Message ---

Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany

WKN:
531370; ISIN: DE0005313704; Index: Prime All Share, TECH All Share,
TecDAX;
Listed: Freiverkehr in Bayerische Börse München, Freiverkehr in Börse
Stuttgart,
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse, Regulierter Markt in
Frankfurter Wertpapierbörse;
Copyright © Hugin AS 2009. All rights reserved.



 
 ||| Themen-Infos 
· Mehr zu dem Thema Personnel changes & Stock activities & P

Der meistgelesene Artikel zu dem Thema Personnel changes & Stock activities & P:
Julius Baer: Two appointments to the Executive Board of Bank Julius Baer

 ||| Artikel Bewertung 
durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht



Web site engine's code is Copyright © 2003 by PHP-Nuke. All Rights Reserved. PHP-Nuke is Free Software released under the GNU/GPL license.
Erstellung der Seite: 0.061 Sekunden